FSSAI Ka Danda Chala, Market Mein Ghabrahat
Sunoo bhai log, FSSAI ne ekdum tight order pass kiya hai. October 2025 se rule hai ki agar koi bhi drink World Health Organization (WHO) ke norms meet nahi karega, use ORS ka label nahi milega. Iske chalte, March mein ORS sales ekdum se 26% niche aa gayi. Last year March mein jahan sales ₹115 Crore thi, woh ab kam hokar bas ₹85 Crore reh gayi. February mein bhi aisa hi hua tha. Toh overall market 8% down hai last 12 months mein, jo ki pehle ke 13% CAGR se kaafi alag hai.
FDC Electral Pe Bhi Asar
Ab bhai, iska asar toh bade players par bhi hua hai. FDC, jinka Electral brand market ka 50% se zyada share rakhta tha, unki sales bhi 7% gir gayi hai. Matlab, jab regulations strict hote hain, toh kisi ko bhi dikkat aa sakti hai.
Naye Khiladi Maidan Mein, Competition Tight
Aur suno, sirf pharma companies hi nahi, ab toh bade FMCG players bhi is field mein aa rahe hain. Unilever apne Liquid IV aur Reliance apne RasKik ke saath. Wahi, Cipla ka Prolyte ORS kaafi fast grow kar raha hai, last 3 saal mein 5 guna badh gaya. Log ab scientifically approved aur healthier options chahte hain.
Fake Claims Ka Khel Khatam
Is puri gadbad ka reason ye bhi hai ki kai saalon se kuch companies ne medical terms use karke, jismein sugary drinks bhi the, logo ko ORS keh kar bechte rahe. FSSAI ne ab ispar rok laga di hai. Jinka business fake claims par chalta tha, unki toh band baj gayi. Ab sabko WHO standards follow karne honge aur saaf-saaf communication karni hogi taaki log trust kar sakein. India ka OTC healthcare market toh waise bhi grow kar raha hai, toh ORS segment ko bhi adapt karna padega. FDC jaise companies ko bhi ab apne products ko iske hisaab se badalna hoga aur transparent rehna hoga.
